MindBio Therapeutics Files Patent Applications for AI Voice Intoxication Detection Technology

MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF), a biotechnology company focused on AI-driven voice analysis for intoxication detection, announced the filing of patent applications for its technology that uses artificial intelligence to analyze human voice patterns and detect drug and alcohol intoxication. The company's Edge AI Intoxication Detection Kiosks leverage over 50 million data points to predict intoxication levels with high accuracy, according to the press release.

The technology is being developed for enterprise applications, with commercial testing hardware and software solutions for the mining and aviation industries on track for delivery by the end of Q2 2026. The company aims to address safety concerns in high-risk environments where impairment can lead to accidents. The kiosks integrate bespoke hardware and software to analyze voice samples in real-time, providing immediate results without the need for invasive testing.

The patent filings cover the proprietary AI algorithms and methods used to detect intoxication from voice recordings. MindBio's AI model has been trained on a vast dataset to identify subtle changes in vocal characteristics that correlate with alcohol or drug impairment. The company positions this technology as a non-intrusive, rapid screening tool that could be deployed in various settings, including construction sites and law enforcement checkpoints.

This development is significant because it represents a shift toward voice-based biometric screening as an alternative to traditional breathalyzers or saliva tests. The technology could potentially reduce workplace accidents and improve public safety by enabling quick, accurate impairment detection. The mining and aviation industries, where operator alertness is critical, stand to benefit from such tools.

For more details on the announcement, visit the full press release here. Additional information about MindBio Therapeutics is available in the company's newsroom at https://nnw.fm/MBQIF.